Press Releases Celyad Oncology SA

Equities

CYAD

BE0974260896

Real-time Euronext Bruxelles Other stock markets 10:49:21 2024-04-30 am EDT			5-day change	1st Jan Change
0.3275 ^EUR	-0.76%		-0.76%	-16.03%

Apr. 04	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 09	Celyad Oncology Seeks Termination of Reporting Obligations to US SEC	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celyad Oncology reports full year 2023 financial results and recent business highlights	Apr. 05	AQ
Celyad Oncology : Report of the Statutory Auditor on the Consolidated Annual Account 2023 ENG	Apr. 05	PU
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook	Jan. 16	AQ
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	Dec. 20	AQ
Celyad announces management change	Dec. 04	AQ
Celyad Oncology : announces management change	Dec. 01	PU
Celyad Oncology : reports third quarter 2023 financial results and recent business highlights - Form 6-K	Nov. 24	PU
Celyad Oncology SA - Publication of a transparency notification received from Fortress Investment Group LLC	Nov. 22	AQ
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	Nov. 21	AQ
Celyad Oncology : CONVENING LETTER TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 22 DECEMBER 2023 - Form 6-K	Nov. 21	PU
Celyad Oncology reports third quarter 2023 financial results and recent business highlights	Nov. 09	AQ
Celyad Oncology : CONVENING LETTER TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 14 NOVEMBER 2023 - Form 6-K	23-10-27	PU
Celyad Oncology announces the termination of its American Depository Receipt program	23-09-25	AQ
Celyad Oncology : Articles of Associations - informal version - EN	23-09-22	PU
Celyad Oncology : Convening letter to the extraordinary general meeting - EN	23-09-22	PU
Celyad Oncology : CONVENING LETTER TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF 25 OCTOBER 2023 - Form 6-K	23-09-21	PU
Celyad Oncology : Press Release - Regulated Information - Form 6-K	23-09-18	PU
Celyad Oncology SA - Publication of a rectified transparency notification received from Fortress Investment Group LLC	23-09-18	AQ
Celyad Oncology : Press release issued by the registrant on September 12, 2023 - Form 6-K	23-09-13	PU
Celyad Oncology SA - Publication of a transparency notification received from Tolefi SA	23-09-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Celyad Oncology SA

Equities

CYAD

BE0974260896

Press Releases

Filters